Structural Entry Filters:

Search Count: 43

Download
8BW0 image
Structure Of Ceacam5 A3-B3 Domain In Complex With Tusamitamab Fab

7A1W image
Krasg12C Gdp Form In Complex With Cpd3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.76 Å Release Date: 2021-10-13
Classification: ONCOPROTEIN
Ligands: GDP, MG, PO4, QWK

7A1X image
Krasg12C Gdp Form In Complex With Cpd1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.32 Å Release Date: 2021-10-13
Classification: ONCOPROTEIN
Ligands: GDP, MG, QWB

7A1Y image
Krasg12C Gdp Form In Complex With Cpd2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.00 Å Release Date: 2021-10-13
Classification: ONCOPROTEIN
Ligands: QWH, GDP, MG, SO4

7A47 image
Krasg12C Gdp Form In Complex With Cpd4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.16 Å Release Date: 2021-10-13
Classification: ONCOPROTEIN
Ligands: GDP, QY5

6RO0 image
Crystal Structure Of Genetically Detoxified Pertussis Toxin Gdpt.

6O89 image
Anti-Cd28Xcd3 Codv Fab

6O8D image
Anti-Cd28Xcd3 Codv Fab Bound To Cd28

6FG1 image
Crystal Structure Of Fab Of Natalizumab In Complex With Fab Of Naa32.

6FG2 image
Crystal Structure Of Fab Of Natalizumab In Complex With Fab Of Naa84.

5LX3 image
Crystal Structure Of Visfatin In Complex With Sar154782.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.10 Å Release Date: 2017-10-25
Classification: TRANSFERASE
Ligands: 7A1

5LX5 image
Crystal Structure Of Visfatin In Complex With Sar154782-Rp.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.88 Å Release Date: 2017-10-25
Classification: TRANSFERASE
Ligands: 7A0, DPO

4V0I image
Water Network Determines Selectivity For A Series Of Pyrimidone Indoline Amide Pi3Kbeta Inhibitors Over Pi3K-Delta
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Resolution:2.54 Å Release Date: 2015-09-30
Classification: TRANSFERASE
Ligands: J82

4UUQ image
Crystal Structure Of Human Mono-Glyceride Lipase In Complex With Sar127303
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.36 Å Release Date: 2015-01-21
Classification: HYDROLASE
Ligands: 64D

4UWF image
Discovery Of (2S)-8-((3R)-3-Methylmorpholin-4-Yl)-1-(3-Methyl-2-Oxo- Butyl)-2-(Trifluoromethyl)-3,4-Dihydro-2H-Pyrimido(1,2-A)Pyrimidin-6- One: A Novel Potent And Selective Inhibitor Of Vps34 For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.99 Å Release Date: 2014-11-26
Classification: TRANSFERASE
Ligands: EUT

4UWG image
Discovery Of (2S)-8-((3R)-3-Methylmorpholin-4-Yl)-1-(3-Methyl-2-Oxo- Butyl)-2-(Trifluoromethyl)-3,4-Dihydro-2H-Pyrimido(1,2-A)Pyrimidin-6- One: A Novel Potent And Selective Inhibitor Of Vps34 For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.70 Å Release Date: 2014-11-26
Classification: TRANSFERASE
Ligands: SO4, RBQ

4UWH image
Discovery Of (2S)-8-((3R)-3-Methylmorpholin-4-Yl)-1-(3-Methyl-2-Oxo- Butyl)-2-(Trifluoromethyl)-3,4-Dihydro-2H-Pyrimido(1,2-A)Pyrimidin-6- One: A Novel Potent And Selective Inhibitor Of Vps34 For The Treatment Of Solid Tumors

4UWK image
Discovery Of (2S)-8-((3R)-3-Methylmorpholin-4-Yl)-1-(3-Methyl-2-Oxo- Butyl)-2-(Trifluoromethyl)-3,4-Dihydro-2H-Pyrimido(1,2-A)Pyrimidin-6- One: A Novel Potent And Selective Inhibitor Of Vps34 For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.83 Å Release Date: 2014-11-26
Classification: TRANSFERASE
Ligands: SO4, GOL, UJB

4UWL image
Discovery Of (2S)-8-((3R)-3-Methylmorpholin-4-Yl)-1-(3-Methyl-2-Oxo- Butyl)-2-(Trifluoromethyl)-3,4-Dihydro-2H-Pyrimido(1,2-A)Pyrimidin-6- One: A Novel Potent And Selective Inhibitor Of Vps34 For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.80 Å Release Date: 2014-11-26
Classification: TRANSFERASE
Ligands: SO4, 7A5

4UYN image
Sar156497 An Exquisitely Selective Inhibitor Of Aurora Kinases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.90 Å Release Date: 2014-11-19
Classification: TRANSFERASE
Ligands: Y3M
Protein Functional Filters:
Feedback Form
Name
Email
Institute
Feedback